A detailed history of Invesco Ltd. transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 12,178 shares of CAPR stock, worth $223,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,178
Previous 12,134 0.36%
Holding current value
$223,344
Previous $57,000 224.56%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.56 - $15.21 $156 - $669
44 Added 0.36%
12,178 $185,000
Q2 2024

Aug 13, 2024

BUY
$4.63 - $7.09 $56,180 - $86,030
12,134 New
12,134 $57,000

Others Institutions Holding CAPR

About CAPRICOR THERAPEUTICS, INC.


  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $447M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.